Myomo (MYO) Debt Ratio (2017 - 2025)
Myomo's (MYO) quarterly Debt Ratio came in at 0.36 in Q4 2025, up 35.97% YoY from 0.27 in Q4 2024, and up 260.25% on a QoQ basis from 0.1 in Q3 2025.
Myomo (MYO) Debt Ratio (2017 - 2025) Analysis & Trends
Myomo (MYO) has 5 years of Debt Ratio data on file, last reported at 0.36 in Q4 2025.
- Quarterly Debt Ratio rose 35.97% year-over-year to 0.36 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.36 (up 35.97% YoY) and the FY2025 annual result came in at 0.36, up 35.97% from the prior year.
- Debt Ratio improved to 0.36 in Q4 2025, from 0.1 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.36 in Q4 2025 to a low of 0.1 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.18 |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.10 |
| Dec 31, 2024 | 0.27 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.40 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.15 |
| Jun 30, 2017 | 0.11 |